Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection

Pediatric Infectious Disease Journal

Volumn 34, Issue 1, 2015, Pages 35-39

  Howley, Meredith M ^a   Painter, John A ^a   Katz, Dolores J ^a   Graviss, Edward A ^b   Reves, Randall ^c   Beavers, Suzanne F ^a   Garrett, Denise O ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

Foreign birth; Interferon gamma release assay; Latent tuberculosis infection; Tuberculin skin test; Tuberculosis

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL EVALUATION; FEMALE; HUMAN; IMMIGRANT; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LATENT TUBERCULOSIS INFECTION; MAJOR CLINICAL STUDY; MALE; MEXICO; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PHILIPPINES; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; TASK PERFORMANCE; TUBERCULIN TEST; UNITED STATES; VIET NAM; INTERFERON GAMMA RELEASE ASSAY; MASS SCREENING; MIGRANT; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; SKIN TEST;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MASS SCREENING; PROSPECTIVE STUDIES; SKIN TESTS; TUBERCULIN TEST; UNITED STATES;

EID: 84926178050     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000494     Document Type: Article

References (39)

1. Pareek M, Baussano I, Abubakar I, et al. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis [serial on the Internet]. 2012. Accessed June 23, 2014.
2. Menzies HJ, Winston CA, Holtz TH, et al. Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994-2007. Am J Public Health. 2010;100:1724-1729.
3. Marais BJ, Obihara CC, Warren RM, et al. The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis. 2005;9:1305-1313.
4. Marais BJ. Tuberculosis in children. Pediatr Pulmonol. 2008;43:322-329.
5. Munoz FM, Starke JR. Tuberculosis in Children. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. 2nd ed. New York, NY: Marcel Dekker, Inc; 2000:516-555.
6. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2000;49:(No-RR-6).
7. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354.
8. World Health Organization. Global and Regional Immunization Coverage, 1980-2007. 2011. Available at: http://www.who.int/immunization-monitoring/diseases/BCG-coverage.jpg. Accessed August 23, 2013.
9. Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis. 2007;20:264-271.
10. Vincenti D, Carrara S, Butera O, et al. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol. 2007;150:91-98.
11. Mahairas GG, Sabo PJ, Hickey MJ, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996;178:1274-1282.
12. Gey van Pittius NC, Sampson SL, Lee H, et al. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol. 2006;6:95.
13. Bergamini BM, Losi M, Vaienti F, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics. 2009;123:e419-e424.
14. Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15:1018-1032.
15. Chiappini E, Bonsignori F, Accetta G, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review. Int J Immunopathol Pharmacol. 2012;25:335-343.
16. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children. Pediatr Infect Dis J. 2011;30:694-700.
17. Kakkar F, Allen U, Ling D, et al. Tuberculosis in children: new diagnostic blood tests. Paediatr Child Health. 2010;15:529-538.
18. Connell TG, Ritz N, Paxton GA, et al. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT. TB in children. PLoS One. 2008;3:e2624.
19. Haustein T, Ridout DA, Hartley JC, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28:669-673.
20. Thomas B, Pugalenthi A, Patel H, et al. Concordance between tuberculin skin test and interferon-γ assay and interferon-γ response to mitogen in pediatric tuberculosis contacts. Pediatr Pulmonol. 2011;46:1225-1232.
21. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection. United States, 2010. MMWR Morb Mortal Wkly Rep. 2010;59(RR-5);1-25.
22. Centers for Disease Control and Prevention. CDC immigration requirements: technical instructions for tuberculosis screening and treatment. 2009. Available at: http://www.cdc.gov/immigrantrefugeehealth/pdf/tuberculosisti-2009.pdf. Accessed June 20, 2013.
23. Department of Homeland Security. 2012 Yearbook of Immigration Statistics; Table 2. Available at: http://www.dhs.gov/yearbook-immigration-statistics. Accessed June 20, 2013.
24. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2012. Atlanta, GA: U. S. Department of Health and Human Services, CDC, October 2013.
25. Centers for Disease Control and Prevention. Slide set.epidemiology of pediatric tuberculosis in the United States, 1993-2012. Available at: http://www.cdc.gov/tb/publications/slidesets/pediatricTB/default.htm. Accessed June 18, 2014.
26. Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculous infection. Geneva: World Health Organization; 1988; WHO/TB/88.154.
27. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J. 2005;25:181-185.
28. World Health Organization. Global tuberculosis control 2013. Geneva: World Health Organization; 2013. Available at: http://www.who.int/tb/country/data/profiles/en/index.html. Accessed November 4, 2013.
29. Bianchi L, Galli L, Moriondo M, et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J. 2009;28:510-514.
30. Cruz AT, Geltemeyer AM, Starke JR, et al. Comparing the tuberculin skin test and T-Spot. TB in Children. Pediatrics. 2011;127:e31.
31. Okada K, Mao TE, Mori T, et al. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect. 2008;136:1179-1187.
32. Lighter J, Rigaud M, Eduardo R, et al. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics. 2009;123:30-37.
33. Ling DI, Crepeau CA, Dufresne M, et al. Evaluation of the impact of interferongamma release assays on the management of childhood tuberculosis. Pediatr Infect Dis J. 2012;31:1258-1262.
34. Lucas M, Nicol P, McKinnon E, et al. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax. 2010;65:442-448.
35. Mendez-Echevarria A, Gonzalez-Munoz M, Mellado MJ, et al. Interferon-γ release assay for the diagnosis of tuberculosis in children. Arch Dis Child. 2012;97:514-516.
36. Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007;45:322-328.
37. Moore M, Kozik C, Tracy M, et al. Immigrants and refugee children with tuberculosis infection notifications, San Diego County, 2007-2008. Poster presentation at the American Thoracic Society International Conference, May 2009. Am J Respir Crit Care Med. 2009;179:A4104.
38. Young J, O'Connor ME. Risk factors associated with latent tuberculosis infection in Mexican American children. Pediatrics. 2005;115:e647-e653.
39. Zwerling A, Behr MA, Verma A, et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012.